| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 411.0 | 387.8 | 353.0 |
| Other income | 10.6 | 9.1 | 12.8 |
| Total income | 421.6 | 397.0 | 365.8 |
| Profit before exceptional items & tax | 50.6 | 66.0 | 61.7 |
| Exceptional items | 0.0 | 1.5 | 0.0 |
| Profit before tax | 50.6 | 67.6 | 61.7 |
| Net profit | 37.5 | 50.3 | 43.9 |
| Operating margin | 12.0% | 17.0% | 16.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -14.60% |
|---|---|
| Net profit, quarter on quarter | -25.40% |
| Revenue, year on year | +16.40% |
| Operating profit, year on year | -13.50% |
| Operating profit, quarter on quarter | -34.70% |
BSE results filing, NSE: JLHL. Figures extracted from the filing.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹265.65
- Market cap
- ₹8,709 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 46.4×Sector 57.8×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Management is optimistic as the new Dombivli hospital ramps up, despite it causing a 9.5 crore EBITDA drag this quarter.
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Jupiter Life Line Hospitals reported Q1FY27 revenue growth of 16.2% YoY, while PAT declined 14.7% due to higher depreciation and finance costs from the new Dombivli facility.
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter reports strong FY26 performance with 15.2% revenue growth to ₹1,499.8cr. Focus remains on greenfield expansion in Western India with asset-heavy ownership model.
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter is aggressively expanding in Western India, leveraging its asset-heavy model to build high-capacity flagship hospitals in Mumbai and Pune.